Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,812 | 3,360 | 499 | 1,093 | 1,762 |
| Other current assets | 56 | 34 | 32 | 31 | 64 |
| TOTAL | $1,917 | $3,395 | $554 | $1,124 | $1,853 |
| Non-Current Assets | |||||
| PPE Net | 269 | 200 | 233 | 154 | 174 |
| Intangibles | 255 | 281 | 262 | 274 | 273 |
| Other Non-Current Assets | 224 | 0 | 0 | 0 | 0 |
| TOTAL | $747 | $481 | $495 | $427 | $447 |
| Total Assets | $2,665 | $3,876 | $1,050 | $1,551 | $2,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,579 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 113 | 170 | 61 | 91 | 91 |
| TOTAL | $1,779 | $216 | $182 | $91 | $168 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,651 | 1,144 | 1,177 | 1,173 |
| Other Non-Current Liabilities | 15 | 5 | 3 | 0 | 0 |
| TOTAL | $10 | $1,708 | $1,217 | $1,177 | $1,173 |
| Total Liabilities | $1,789 | $1,923 | $1,399 | $1,268 | $1,340 |
| Shareholders' Equity | |||||
| Common Shares | 4,336 | 4,330 | 3,612 | 3,602 | 3,602 |
| Retained earnings | -8,036 | -6,786 | -5,953 | -5,189 | -4,482 |
| Other shareholders' equity | -5,401 | -5,712 | -5,705 | -5,508 | -5,501 |
| TOTAL | $891 | $1,958 | $-347 | $283 | $959 |
| Total Liabilities And Equity | $2,680 | $3,881 | $1,052 | $1,551 | $2,300 |